Pay in 4 interest-free payments of $6.09 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
2594 Disclaimer: Information and statements regarding the product/services have not been evaluated by the Food and Drug Administration or any government authority and not intended to diagnose, treat, cure, or prevent any disease
Other treatments for your clinic/salon:
A randomized, double-blind, positive-controlled, prospective, dose-response clinical study to evaluate the efficacy and tolerability of an aqueous extract of Terminalia bellerica in lowering uric acid and creatinine levels in chronic kidney disease subjects with hyperuricemia
formal human studies have primarily used doses up to ~300 mcg daily [7]
Khomami MB, Tehrani FR, Hashemi S, Farahmand M, Azizi F
US$ 24.26
US$ 24.57
US$ 24.49
